Valuation: Innova Captab Limited

Capitalization 49.89B 522M 447M 409M 387M 717M 722M 4.88B 1.89B 23.71B 1.96B 1.92B 82.52B P/E ratio 2026
28x
P/E ratio 2027 * 26.3x
Enterprise value 49.89B 522M 447M 409M 387M 717M 722M 4.88B 1.89B 23.71B 1.96B 1.92B 82.52B EV / Sales 2026
2.42x
EV / Sales 2027 * 2.52x
Free-Float
27.81%
Yield 2026 *
-
Yield 2027 * -
1 day-0.34%
1 week+0.96%
Current month+15.94%
1 month+25.58%
3 months+28.44%
6 months+16.05%
Current year+21.08%
1 week 833.05
Extreme 833.05
918
1 month 702.3
Extreme 702.3
918
Current year 622
Extreme 622
918
1 year 622
Extreme 622
1,020.7
3 years 421.35
Extreme 421.35
1,260
5 years 421.35
Extreme 421.35
1,260
10 years 421.35
Extreme 421.35
1,260
Manager TitleAgeSince
Chief Executive Officer 50 2022-03-17
Director of Finance/CFO - 2024-03-29
Chief Tech/Sci/R&D Officer - 2021-02-11
Director TitleAgeSince
Director/Board Member 50 2022-03-17
Chairman 54 2022-03-17
Director/Board Member - 2020-02-27
Change 5d. change 1-year change 3-years change Capi.($)
-0.34%+0.96%-5.86% - 523M
-0.89%+3.26%+40.69%+131.73% 906B
+0.16%+3.73%+57.69%+43.55% 555B
+1.09%+3.98%+18.78%+43.23% 368B
-0.94%-0.94%+23.89%+10.73% 326B
-0.19%+3.20%+37.10%+14.40% 289B
+0.78%+3.09%+30.74%+26.23% 285B
-0.04%+0.99%+54.36%-3.18% 280B
+0.91%+1.25%-30.88%-49.10% 208B
-0.07%+2.17%+28.20%+44.34% 182B
Average +0.23%+1.92%+25.47%+29.10% 339.9B
Weighted average by Cap. +0.40%+2.37%+34.41%+50.46%

Financials

2026 2027 *
Net sales 15.88B 166M 142M 130M 123M 228M 230M 1.55B 603M 7.54B 623M 610M 26.26B 19.82B 207M 178M 162M 154M 285M 287M 1.94B 753M 9.42B 778M 761M 32.79B
Net income 1.39B 14.58M 12.49M 11.42M 10.81M 20.02M 20.18M 136M 52.94M 662M 54.71M 53.55M 2.31B 1.9B 19.85M 17M 15.55M 14.72M 27.25M 27.47M 186M 72.06M 902M 74.48M 72.89M 3.14B
Net Debt - -
Logo Innova Captab Limited
Innova Captab Limited is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
Employees
1,600
Date Price Change Volume
26-05-14 871.90 -0.34% 26,394
26-05-13 874.90 +0.35% 113,985
26-05-12 871.85 +1.94% 70,573
26-05-11 855.25 -2.34% 59,910
26-05-08 875.75 +1.40% 155,822
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
871.90INR
Average target price
971.50INR
Spread / Average Target
+11.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. INNOVACAP Stock